NetworkNewsBreaks – ABcann Global Corp. (TSX.V:
Post# of 102
(Total Views: 133)
Posted On: 05/23/2018 5:56:18 PM
NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Launches New Medical Cannabis Brand
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the launch of its new medical cannabis brand, Beacon Medical. The company developed the brand based on a deep consumer understanding that it obtained through an exclusive study of 1,500 Canadians. The study showed that consumers needed a brand that makes the process of obtaining and using medical cannabis easier to navigate. Beacon Medical intends to help patients and their healthcare provider find the best treatment option amid the complex medical cannabis market by providing excellent customer service, simple registration and product classification, efficient purchasing and pharmaceutical-grade products. The full Beacon Medical website and product line, including cannabis oils, is anticipated to be available to ACMPR patients by early summer 2018. Additionally, investors will be able to get a first look at Beacon Medical at the Lift Expo taking place in Toronto from May 25t to 27th, 2018. “Our vision is to leverage our unique experience in the global pharmaceutical industry to create one of the most respected medical cannabis companies. The launch of Beacon is an important step towards that vision,” ABcann Global CEO Barry Fishman stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the launch of its new medical cannabis brand, Beacon Medical. The company developed the brand based on a deep consumer understanding that it obtained through an exclusive study of 1,500 Canadians. The study showed that consumers needed a brand that makes the process of obtaining and using medical cannabis easier to navigate. Beacon Medical intends to help patients and their healthcare provider find the best treatment option amid the complex medical cannabis market by providing excellent customer service, simple registration and product classification, efficient purchasing and pharmaceutical-grade products. The full Beacon Medical website and product line, including cannabis oils, is anticipated to be available to ACMPR patients by early summer 2018. Additionally, investors will be able to get a first look at Beacon Medical at the Lift Expo taking place in Toronto from May 25t to 27th, 2018. “Our vision is to leverage our unique experience in the global pharmaceutical industry to create one of the most respected medical cannabis companies. The launch of Beacon is an important step towards that vision,” ABcann Global CEO Barry Fishman stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)